Hormel Foods (HRL) › Analysis

Hormel Foods (HRL) stock analysis, November 3, 2026: Overbought rally inside a weekly downtrend

Published November 3, 2026 · updated 2026-11-04 · HRL chart, levels and live analysis

Update, November 4, 2026

Hormel Foods (HRL) surged 6.9% on November 4, closing at $22.73, and is now up 10.3% over five days, far outpacing the S&P 500 (-0.5%) and the Consumer Staples Select Sector SPDR Fund (XLP, +6.1%) over the same period. The rally has pushed the stock above its 200-day moving average ($22.79) on an intraday basis, though it closed just below that level. The 14-day RSI is at 77, confirming overbought conditions.

The picture holds: the weekly downtrend remains intact, with the price still below its 40-week average. The key resistance at $23.17 (swing zone) has not been tested on a closing basis, and a weekly close above that level would change the picture. The immediate support is at $22.09 (swing zone), and a daily close below that would open the path toward $21.26 and $20.69, with reward-to-risk ratios of 1.0 and 1.7, respectively. The stop at $22.92 (based on the 200-day SMA plus a quarter of ATR) is now closer to the price, but the setup still favors downside.

Volume on the up day was 32% below the 20-day average, suggesting the move lacks conviction. The next earnings release is December 3, and the analyst consensus is hold with a mean target of $25.31, implying 10% upside. A recent SEC filing (Form 8-K) on October 29 noted a director or officer change, but no material impact was disclosed.

Hormel Foods (HRL) stock has bounced about 4.9% over the past month to roughly $21.25, but the bounce sits inside a weekly downtrend and has pushed the 14-day RSI to 69.8, which is overbought. The balance of evidence for the next 2–6 weeks leans negative, with medium conviction. The only company filing in the past week was a routine officer-or-director change, so news does not explain the rise.

Why it matters

On October 29, 2026, Hormel filed a Form 8-K under Item 5.02, the disclosure companies make when directors or executive officers change. The SEC EDGAR filing excerpt does not say who is involved. Without names or roles, it cannot be called good or bad news. Nothing in the data shows the stock reacting to it, and the move since then has to be explained by something else.

That something else is mostly the sector. Over five days HRL gained 1.8%, the S&P 500 fell 2.1%, and the consumer staples ETF (XLP) rose 2.4%. HRL therefore trailed its sector by 0.6 points while moving against the market. Staples have been the strongest part of the tape: XLP is up 10.8% over a month, and HRL's 4.9% gain over the same period is less than half that. Today the pattern ran in reverse. XLP fell 1.7% and HRL fell 1.0%, after a close of $21.47 on November 2, 2026 that marks the recent peak. The stock is following the sector, not leading it.

No articles on HRL's merits turned up this week, so the debate is visible only in the price and the analyst targets. The case for the stock is that it has fallen far while staples have not. HRL is down 10.4% year to date against gains of 14.9% for XLP and 10.5% for the S&P 500, and it sits 19.9% below its 52-week high of $26.51. The case against is that it is still below its 200-day average of $22.80 and below its 40-week average, so the sector's strength has not carried it out of the downtrend.

Eight analysts rate the stock a consensus hold. Their mean price target is $25.31, which is 16.1% above the current price, and even the lowest target of $23.00 is above it. The range runs to $29.00. Targets that sit this far above a stock in a downtrend usually mean the forecasts have not caught up with the price. They are not evidence that the price is wrong.

What the evidence says

The long-term thesis is weakened, not broken. The stock is below its 40-week average and below its 200-day average, and it is down 10.4% this year. It is, however, 10.7% above its 52-week low of $19.19 and above its 10-week average. That is the profile of a counter-trend rally inside a downtrend, not of a recovery that has been confirmed.

For the next 2–6 weeks the balance of evidence leans negative, with medium conviction (2 of 4 points). A rally inside the weekly downtrend has reached overbought. The stock has led the S&P 500 by 4.4% over 50 days, which runs against the trend. It has also lagged XLP by 2.5% over the same span, so it is not even the strongest name in its own group. Volume today is running 44% below its 20-day average, which suggests the rise has not drawn heavy buying.

The strongest case against this reading is the price action itself. HRL is up 1.8% in five days while the market fell 2.1%, it is above its 10-week average, and its 50-day lead over the market is real. If staples keep rising, that strength could carry it through the nearby resistance. It does not tip the balance because the lead over the market is the sector's doing, and HRL is still behind the sector. That gap, along with only two of four points, is why conviction is medium and not higher.

Levels that matter

In a downtrend the structure holds below $21.26, a swing zone where sellers have appeared on earlier rallies. The stock, at about $21.25, is sitting right under it. The trend would end only with a weekly close above $22.09, another swing zone. The 200-day average at $22.80 sits just above, so the area between $21.26 and $22.80 is the overhead ceiling.

On the downside, the breakout level is a daily close below $20.71, the 50-day average. From there the first target is $20.36, a swing zone, at 0.5 to 1 reward to risk. The second is the 52-week low of $19.19, at 2.3 to 1. The stop sits at $21.38, which is $21.26 plus a quarter of the 14-day average true range of $0.47. The math does not reach 3 to 1. It would need a target below $19.19, and the next mapped level there is the round $15.00, or a stop much closer to the entry.

What would change the picture

A weekly close above $22.09 would end the downtrend reading. The non-price fact that could produce it is an earnings report on December 3, 2026 showing that the business is recovering, with sales and guidance improving, so that the rally is backed by results and not by the sector alone.

What to watch

Get a message when the HRL picture changes — the agent team watches the levels and the news for you.Create a free account

More HRL analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.